Women with healthy BMI may have higher risk of breast cancer

April 5, 2017 by Heather Lindsey, Cornell University
Women with healthy BMI may have higher risk of breast cancer
Inflamed breast fat with crown-like structures comprised of immune cells (brown) surrounding fat cell (white). Credit: Weill Cornell Medicine/Memorial Sloan Kettering Cancer Center

Women with a healthy body mass index (BMI) may be at risk of developing breast cancer because of enlarged fat cells in their breast tissue that trigger an inflammatory process, according to a new study from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center researchers.

When these fat cells, or adipocytes, become excessively large, "they can become sick or die, setting off an inflammatory reaction," said senior study author Dr. Andrew Dannenberg, the Henry R. Erle, M.D.-Roberts Family Professor of Medicine and associate director of at the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. This inflammation is associated with molecular changes in the breast and blood, which are known to increase the risk of .

For their study, published March 7 in Cancer Prevention Research, the researchers evaluated fat tissue from the breast and blood samples of 72 patients with normal BMIs – a measure of weight and height defined as less than 25 – who were undergoing mastectomies as a risk-reduction procedure or . They found that 39 percent of women had inflammation of their breast fat tissue.

While doctors often consider an obese patient's risk, they may not automatically think about the risk of malignancy when an individual has a normal BMI, said study lead author Dr. Neil Iyengar, a medical oncologist in the Breast Medicine Service at Memorial Sloan Kettering Cancer Center and an assistant professor of medicine at Weill Cornell Medicine. This research "increases our awareness of a potentially vulnerable population," Iyengar said. "An alarming number of people may be at risk."

Some women with a normal BMI may have an increased amount of body fat "manifesting itself as enlarged adipocytes, predisposing them to inflammation," Dannenberg said. The enlarged sick or dying adipocytes release substances into fat tissue and blood, helping to recruit white blood cells called macrophages that cause inflammation. The macrophages that envelop the dying adipocytes form crown-like structures that reflect inflammation. While "these macrophages eat the dead or sick adipocyte and clear it," the inflammatory process that is likely to contribute to cancer has already begun, Dannenberg said.

Specifically, the researchers found that breast inflammation was associated with an elevation of the enzyme aromatase. Aromatase helps make estrogen, which can encourage the growth of some hormone-sensitive breast tumors.

In addition, they measured high levels of metabolic markers such as insulin and glucose in these patients. "It is similar to prediabetes, which is traditionally considered to be associated with overweight or obesity," Iyengar said. "We call it metabo-inflammation, which means there's inflammation in the fat that has metabolic consequences even in these normal weight women." Prior research has shown that insulin and glucose increase and shorten survival of women with the disease.

Based on the current study, the investigators are now assessing body composition using a dual-energy X-ray absorptiometry (DEXA) scan, typically used to measure bone density, and trying to determine whether increased body fat or blood biomarkers might identify women with healthy BMIs who have underlying inflamed fat.

"If we can develop a noninvasive test to identify those with inflamed fat," Dannenberg said, "we will be positioned to reduce the risk of cancer."

Once diagnosed, the goal is to offer interventions such as diet and exercise that may influence and metabolic health, Iyengar said. Future research is needed to answer the question of why people with healthy BMIs develop this inflammatory state. "We don't currently know the precise reasons," Iyengar said, "but it will be important to examine diet and activity levels to see if any patterns emerge and to ultimately develop effective cancer prevention and treatment strategies."

Explore further: Breast density research edges closer to cancer prevention

Related Stories

Breast density research edges closer to cancer prevention

January 24, 2017
Adelaide researchers are one step closer to breast cancer prevention after finding a new driver for breast density, an identified risk factor for breast cancer.

ASCO: BMI, menopause status linked to breast inflammation

September 5, 2014
(HealthDay)—Body mass index (BMI) and postmenopausal status are independently associated with breast white adipose tissue (WAT) inflammation, according to a study scheduled to be presented at the American Society of Clinical ...

Researchers quantify immune cells associated with future breast cancer risk

February 8, 2017
Researchers from Mayo Clinic have quantified the numbers of various types of immune cells associated with the risk of developing breast cancer. The findings are published in a study in Clinical Cancer Research.

Research links obesity to poor survival in tongue cancer patients

February 5, 2014
(Medical Xpress)—Cancer experts from Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College are working side by side to unravel the mysterious link between obesity and cancer. Most recently, their collaborative ...

Obesity associated with increased breast cancer risk in postmenopausal women

June 11, 2015
An analysis of extended follow-up data from the Women's Health Initiative clinical trials suggests that postmenopausal women who were overweight and obese had an increased risk of invasive breast cancer compared to women ...

Breast cancer awareness: What women need to know

September 28, 2016
As national Breast Cancer Awareness Months begins next week, breast health expert Dr. Sharon Koehler of New York Institute of Technology College of Osteopathic Medicine, says women need to know the following five things:

Recommended for you

Study tracks evolutionary transition to destructive cancer

February 23, 2018
Evolution describes how all living forms cope with challenges in their environment, as they struggle to persevere against formidable odds. Mutation and selective pressure—cornerstones of Darwin's theory—are the means ...

Researchers use a molecular Trojan horse to deliver chemotherapeutic drug to cancer cells

February 23, 2018
A research team at the University of California, Riverside has discovered a way for chemotherapy drug paclitaxel to target migrating, or circulating, cancer cells, which are responsible for the development of tumor metastases.

Lab-grown 'mini tumours' could personalise cancer treatment

February 23, 2018
Testing cancer drugs on miniature replicas of a patient's tumour could help doctors tailor treatment, according to new research.

An under-the-radar immune cell shows potential in fight against cancer

February 23, 2018
One of the rarest of immune cells, unknown to scientists a decade ago, might prove to be a potent weapon in stopping cancer from spreading in the body, according to new research from the University of British Columbia.

Putting black skin cancer to sleep—for good

February 22, 2018
An international research team has succeeded in stopping the growth of malignant melanoma by reactivating a protective mechanism that prevents tumor cells from dividing. The team used chemical agents to block the enzymes ...

Cancer risk associated with key epigenetic changes occurring through normal aging process

February 22, 2018
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.